Literature DB >> 12208178

Three hypotheses linking bile to carcinogenesis in the gastrointestinal tract: certain bile salts have properties that may be used to complement chemotherapy.

Dennis H Stamp1.   

Abstract

The literature for the proliferative effect of bile acids on the GI tract has been reviewed and three hypotheses developed regarding their carcinogenicity. Considered as a unit, the GI tract is protected from this carcinogenicity in different ways in the esophagus, stomach, small bowel and colon. Uncharged BAs can enter the esophageal epithelial cells by reflux of gastroduodenal juices in humans, and in animals by surgical alteration of the GI tract or by adding bile concentrate to the diets, and this can initiate GERD and eventually cancer. Acid suppressant therapy used to treat GERD patients, converts stomach pH to >4. This will remove the charges on conjugated bile acids allowing them entry into the epithelium thus casting doubt on the efficacy of acid suppression. From these observations, we postulate that (a) uncharged BA in daily contact with the esophagus can cause GERD and eventually cancer. This might explain the cancers obtained by Fein et al. (b) Clinical trials designed to test the effectiveness of acid suppressants will be meaningless since up to approximately 87% of these patients (in one study) have bile in their refluxate, and this, combined with acid suppressants, will initiate carcinogenesis. (c) Bile reaching a colon made sterile by antibiotics or other means, will not be deconjugated and so, with pKa's of 2 and 4, will be uncharged and therefore can easily enter the colonic cells where the pH is >6. This should be of some concern, especially on a high-fat diet when more bile enters the colon. A group of physicians noted that approximately 47% of patients with esophageal cancers also had some form of colon cancer and postulated that an etiological factor in the environment was responsible. Could this factor be bile? Reactions of certain bile salts with epithelial cells suggest a useful role for them in chemotherapy. Experiments to test hypotheses a, b and c are presented in the addendum.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208178     DOI: 10.1016/s0306-9877(02)00125-1

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  16 in total

Review 1.  Upper aerodigestive tract disorders and gastro-oesophageal reflux disease.

Authors:  Andrea Ciorba; Chiara Bianchini; Michele Zuolo; Carlo Vittorio Feo
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

Review 2.  Interaction of gut microbiota with bile acid metabolism and its influence on disease states.

Authors:  Alexander Khoruts; Michael J Sadowsky; Christopher Staley; Alexa R Weingarden
Journal:  Appl Microbiol Biotechnol       Date:  2016-11-25       Impact factor: 4.813

Review 3.  Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD.

Authors:  Ken-ichi Mukaisho; Tadashi Hagiwara; Takahisa Nakayama; Takanori Hattori; Hiroyuki Sugihara
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development.

Authors:  Rengasamy R M Maran; Ann Thomas; Megan Roth; Zhonghua Sheng; Noriko Esterly; David Pinson; Xin Gao; Yawei Zhang; Vadivel Ganapathy; Frank J Gonzalez; Grace L Guo
Journal:  J Pharmacol Exp Ther       Date:  2008-11-03       Impact factor: 4.030

5.  Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia.

Authors:  I Leeuwenburgh; P Scholten; T J Caljé; R J Vaessen; H W Tilanus; B E Hansen; E J Kuipers
Journal:  Dig Dis Sci       Date:  2012-11-22       Impact factor: 3.199

6.  Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome.

Authors:  Brian V Jones; Máire Begley; Colin Hill; Cormac G M Gahan; Julian R Marchesi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

Review 7.  Targeting gut dysbiosis as a means to enhance recovery from surgical brain injury.

Authors:  Sarah Danehower
Journal:  Surg Neurol Int       Date:  2021-05-03

8.  Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids.

Authors:  Ken-Ichi Mukaisho; Takahisa Nakayama; Tadashi Hagiwara; Takanori Hattori; Hiroyuki Sugihara
Journal:  Front Microbiol       Date:  2015-05-11       Impact factor: 5.640

9.  Continuous taurocholic acid exposure promotes esophageal squamous cell carcinoma progression due to reduced cell loss resulting from enhanced vascular development.

Authors:  Sho Sato; Hiroto Yamamoto; Ken-Ichi Mukaisho; Shota Saito; Takanori Hattori; Gaku Yamamoto; Hiroyuki Sugihara
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

Review 10.  Bile acid nuclear receptor FXR and digestive system diseases.

Authors:  Lili Ding; Li Yang; Zhengtao Wang; Wendong Huang
Journal:  Acta Pharm Sin B       Date:  2015-02-25       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.